Stephen Stefani
Impact in
-
- Cancer Genomics and Diagnostics
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 8
- Economic and Financial Impacts of Cancer 6
- Pharmaceutical Economics and Policy 3
-
- Public Health in Brazil 7
- Co-authors
- David M. Thomas (1 shared paper)Jorge S. Reis‐Filho (1 shared paper)Emile E. Voest (1 shared paper)C. Benedikt Westphalen (1 shared paper)Joaquı́n Mateo (1 shared paper)Philippe Aftimos (1 shared paper)Lotte Steuten (1 shared paper)D. M. Davies (1 shared paper)
- Journals
- Value in Health (6 papers)Journal of Clinical Oncology (3 papers)The Lancet Oncology (2 papers)Frontiers in Pharmacology (1 paper)Therapeutic Advances in Medical Oncology (1 paper)
- Partner nations
- BrazilUnited StatesGermany
In The Last Decade
Stephen Stefani
26 papers receiving 339 citations
Stephen Stefani's Hit Papers
Peers
Comparison fields: 5 of 76
- Health Informatics 9
- Cancer Research 83
- Oncology 62
- Pulmonary and Respiratory Medicine 60
- Internal Medicine 4
Countries citing papers authored by Stephen Stefani
This map shows the geographic impact of Stephen Stefani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Stefani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Stefani more than expected).
Fields of papers citing papers by Stephen Stefani
This network shows the impact of papers produced by Stephen Stefani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Stefani. The network helps show where Stephen Stefani may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Stefani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Delivering precision oncology to patients with cancer Hit paper breakdown → | 2022 | 216 |
| 2 | Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine. | 2001 | 25 |
| 3 | 2011 | 13 | |
| 4 | 2016 | 12 | |
| 5 | 2021 | 10 | |
| 6 | 2008 | 9 | |
| 7 | 2021 | 9 | |
| 8 | 2017 | 7 | |
| 9 | Tromboembolia pulmonar em necropsias no Hospital de Clínicas de Porto Alegre, 1985-1995 | 1997 | 6 |
| 10 | 2018 | 6 | |
| 11 | 2003 | 5 | |
| 12 | 2019 | 5 | |
| 13 | 2012 | 4 | |
| 14 | 2020 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2019 | 2 | |
| 17 | 2019 | 2 | |
| 18 | 2019 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2022 | 1 |
About Stephen Stefani
Stephen Stefani is a scholar working on Economics and Econometrics, Sociology and Political Science, Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 344 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Public Health in Brazil (7 papers), Economic and Financial Impacts of Cancer (6 papers), Cancer Genomics and Diagnostics (5 papers), Pharmaceutical Economics and Policy (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Prostate Cancer Treatment and Research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Health Informatics (9 citations), Cancer Research (83 citations), Oncology (62 citations), Pulmonary and Respiratory Medicine (60 citations) and Internal Medicine (4 citations). Stephen Stefani has collaborated with scholars based in Brazil, United States and Germany. Frequent co-authors include David M. Thomas, Jorge S. Reis‐Filho, Emile E. Voest, C. Benedikt Westphalen, Joaquı́n Mateo, Philippe Aftimos, Lotte Steuten, D. M. Davies, Jan Geißler and Don Husereau. Their work appears in journals such as Value in Health, Journal of Clinical Oncology, The Lancet Oncology, Frontiers in Pharmacology and Therapeutic Advances in Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.